Edesa Biotech, Inc. · NASDAQ:EDSA
Pardeep Nijhawan reported a 19.99% stake in Edesa Biotech, Inc. (Schedule 13D/A)
Event Feb 26, 2026 · Filed Mar 2, 2026
Pardeep Nijhawan reported a 19.99% stake in Edesa Biotech, Inc., 2,040,785 shares, with active intent on Feb 26, 2026. Filed Mar 2, 2026 (Schedule 13D/A).
- Stake
- 19.99%
- Shares
- 2,040,785
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Pardeep Nijhawan Medicine Professional Corporation | 11.90% | 1,133,676 |
| The Digestive Health Clinic Inc. | 0.40% | 32,013 |
| 1968160 Ontario Inc. | 0.60% | 53,104 |
| The New Nijhawan Family Trust 2015 | 0.40% | 32,609 |
| Pardeep Nijhawan | 19.99% | 2,040,785 |
Source
Related
- Edesa Biotech, Inc.
- Nijhawan Pardeep
- Edesa Biotech, Inc. shareholders
- Schedule 13D/A · Nijhawan Pardeep · Aug 25, 2026
- Schedule 13D/A · Nijhawan Pardeep · Jun 16, 2026
- Schedule 13D/A · Nijhawan Pardeep · Feb 14, 2025
- Form 4 · Nijhawan Pardeep · Oct 6, 2026
- Form 4 · Nijhawan Pardeep · Sep 1, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Aug 26, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Aug 25, 2026
- Form 4 · Nijhawan Pardeep · Aug 4, 2026